SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Roche Receives FDA De Novo Authorization for Mass Spectrometry Platform

The FDA authorized Roche’s cobas pro i 601 platform with the Ionify Gabapentin assay for its cobas Mass Spec solution.

RO

Related stories